At present, the retrievable umbrella-type cava filters listed in China are all imported brands. balloon catheter As the first retrievable umbrella-type vena cava filter in China, what are the innovations of Octoparms®?
It is the first umbrella-type structure in China to prolong the retrieve period of the vena cava filter. The prolongation of the retrieve period can ensure the thrombus interception and improve the retrieve rate, reduce the clinical risk caused by the transformation into the permanent implanted filter. It gives doctors more choices, and have significant clinical application value.
The major innovation in material technology, and coaxial design of the conveying system ensures accurate release and recovery of products, avoiding inclination and displacement. The laser integrated cutting design improves the anti-fracture and anti-corrosion performance of the product.
In clinical trials, Octoparms® vena cava filter has been highly praised by experts. Liu Jianlong, Professor of Vascular Surgery Department of Beijing Jishuitan Hospital, said in the online live broadcast of the Vascular Innovation Symposium on May 16, 2020: “We think this filter has a long retrieve time and relatively easy operation, and has good effects both from the cervical and femoral directions!”
Octoparms® vena cava filter has three elements of ideal filter: safety, reliability and recyclability. It has been completed all clinical trials and in the stage of registration. Passing the special approval for innovative products, it will speed up the listing process. It is expected to obtain the NMPA registration certificate by the end of this year. It is believed that it will play a brilliant role in clinical application and become a winning tool in the hands of doctors.
The market scale of vena cava filter is billions and its annual growth rate is 20% – 30%. With the growth of market demand and the acceleration of import substitution, more domestic filters will enter the market. Kossel Medtech strives to become an excellent innovative enterprise of vascular interventional medical devices and develop more innovative products, to make more patients benefit.